Programme
12.30   Registration
13.00 Workshop introduction
13.15 In vitro systems for mechanistic evaluation of drug-drug interactionrisk associated with peptide analogues 
Carolina Säll/Deepak Kumar Bhatt, Novo Nordisk
14.00 The impact of septic shockon the phamacokinetics and pharmacodynamics of selepressin
Daniel Jonker, Ferring
14.35 MS processing software for peptide met-ID (working title)
Jan Boerma, UniLabs
15.10 Coffee break
15.40 Peptide drug metabolism profiling in preclinical drug development 
Simon Hauri, Roche
16.15 A company strategy for immunogenicity testing of peptide drugs
Birgitte Buur Rasmussen, Ferring
16.50 Automated LC-MS based in vitro assay to asses protease stability of pharmacologically active peptides for inhalation
Frank Wesche, AZ
17.25 Free session discussion/meeting roundup
19.00 Drinks/dinner (at own expense)